| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $19.5M | -5.4% |
| SG&A Expense | $14.5M | +14.2% |
| Operating Income | -$43.8M | +3.8% |
| Interest Expense | $20.0M | +8.1% |
| Pre-tax Income | -$60.9M | -10.7% |
| Income Tax | $0 | — |
| Net Income | -$60.9M | -10.7% |
| EPS (Basic) | -$2.63 | -0.8% |
| EPS (Diluted) | -$2.63 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $49.6M | -53.3% |
| Inventory | $1.4M | -26.2% |
| Current Assets | $54.6M | -51.9% |
| Total Assets | $140.1M | -30.5% |
| Current Liabilities | $5.8M | -50.7% |
| Long-term Debt | $125.0M | -13.8% |
| Total Liabilities | $173.6M | -8.2% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$35.9M | +13.4% |
| Capital Expenditures | $1.3M | +17.1% |
| Investing Cash Flow | $6.3M | +1347.9% |
| Financing Cash Flow | -$25.9M | -1674.3% |
| Free Cash Flow | -$37.1M | +12.6% |
| -0.8% |
| Stockholders' Equity |
| -$33.4M |
| -364.0% |